All news
New Era in Gastric Cancer Treatment: Zolbetuximab Gains EU Approval
26 October 2024On September 20th, 2024, the European Commission approved zolbetuximab with chemotherapy for advanced Gastric and GastroEsophageal Junction cancers...
DiCE Proud to Be Part of #UEGWeek2024
25 October 2024Collaboration and partnerships are fundamental to our work, so it was a pleasure to participate in UEG Week again this year, held in Vienna. It pro...
Help Shape the Future of Gastric Cancer Screening in Europe
25 September 2024The TOGAS consortium invites you to participate in a survey on gastric cancer screening. TOGAS is an EU co-funded project exploring the implementat...
The POLAR Promise: Groundbreaking Survival Gains for Targeted Pancreatic Cancer Patients in Phase II Trial
25 September 2024Phase II trial of Pembrolizumab Immunotherapy and Olaparib (POLAR) trial new data presented at the European Society for Medical Oncology (ESMO) 202...
DiCE at ESMO 2024
24 September 2024Earlier this month, part of the DiCE Medical and Scientific Team attended the ESMO (European Society for Medical Oncology) Congress 2024 in Barcelo...
Calling All Full Members! Applications are now Open for the Wolfram Nolte Memorial Award for Colorectal Cancer Projects
23 September 2024The Wolfram Nolte Award of €5.000 is Open for Applications from DiCE Full Members until 18 October 2024.
...
Early-Age Onset Digestive Cancers – a Global Review of this Worrisome Trend
22 August 2024Early-age onset digestive cancers are worrisomely on the rise. To bring awareness to this topic, DiCE is partnering with its Member Organisation,...
PerMICCion: A Study on Transforming Colorectal Cancer Prevention and Treatment through Gut Microbiome Research
26 July 2024A groundbreaking study in Germany, known as PerMICCion, is investigating how understanding the microorganisms in our gut, known as the gut microbio...
Appeal to President von der Leyen to Appoint a Vice-President for Health, Wellbeing, and Social Rights
25 July 2024DiCE and 30 organisations brought together by the EU4Health Civil Society Alliance have published a letter to European Commission President nominee...
Von der Leyen’s Reelection Could Mean Continuity, Yet Shifts in Health Priorities May Impact Cancer Funding
24 July 2024Ursula von der Leyen has been re-elected as President of the European Commission, signaling a potential shift in political priorities away from hea...
